In the wake two recent studies linking testosterone replacement therapy to an INCREASED risk of heart disease and stroke, the Federal Drug Administration has announced plans to independently investigate any possible connection.
I wish to mention two pieces of information. The first is that there are dozens, and perhaps hundreds, of studies showing a benefit to testosterone replacement therapy. These two studies are the only studies showing a negative impact. Both of these studies have come under fire for their design and the experts in the field view the results with skepticism.
The second point I would like to make is that the FDA also announced that: “At this time, FDA has not concluded that FDA-approved testosterone treatment increases the risk of stroke, heart attack, or death. Patients should not stop taking prescribed testosterone products without first discussing any questions or concerns with their health care professionals. Health care professionals should consider whether the benefits of FDA-approved testosterone treatment is likely to exceed the potential risks of treatment.”
This is incredibly interesting because, in my experience, the FDA has been very cautious and is quick to affix warnings on drugs. Take a look at the FDA website for evidence of this. The fact that the FDA specifically warned patients not to stop their therapy speaks volumes of their perception of these studies.
Erectile Dysfunction Specialists of Arizona is paying close attention to this issue and will keep our readers and patients informed of any new developments. If anyone has any questions or comments, please feel free to contact me and, as always, I will respond as promptly as I can.